Name: Panel: Pioneering Early-Stage Cancer Therapies: Harnessing Therapeutic Cancer Vaccines for Precision Medicine
Start: 2024-10-01T12:15:00-0400
End: 2024-10-01T13:00:00-0400

Tuesday October 1, 2024 12:15pm - 1:00pm EDT

This session dives into the transformative potential of therapeutic cancer vaccines in early-stage drug development within the biotech industry. Recent breakthroughs, including an mRNA cancer vaccine's success against glioblastoma, highlight a promising avenue for creating targeted and personalized therapies. Discover how this innovative technology can be harnessed to create personalized therapies, advance precision medicine, and revolutionize patient care. Explore the strategic integration of therapeutic cancer vaccines into drug development pipelines, and gain valuable insights into refining protocols, identifying candidate selection, and navigating regulatory pathways.

Speakers

Scot W. Ebbinghaus M.D.

Vice President and Therapeutic Area Head Oncology Late Stage Development, Merck Research Laboratories

Dr. Scot Ebbinghaus joined Merck Research Labs Late Stage Oncology Development in 2007. He is currently Vice President and Therapeutic Area Head for Late Stage Oncology Development.Dr. Ebbinghaus has played key roles in the development of the lead indication for KEYTRUDA® in melanoma... Read More →

Tuesday October 1, 2024 12:15pm - 1:00pm EDT

Track: Early-Stage Development

Fierce Biotech Summit 2024

Scot W. Ebbinghaus M.D.

Log in to save this to your schedule, view media, leave feedback and see who's attending!